Search results
Bristol Myers Squibb Company (BMY) Is a Trending Stock: Facts to Know Before Betting on It
Zacks via Yahoo Finance· 3 months agoBristol Myers Squibb (BMY) has recently been on Zacks.com's list of the most searched stocks....
Bristol Myers Squibb (BMY) Stock Declines While Market Improves: Some Information for Investors
Zacks via Yahoo Finance· 3 months agoBristol Myers Squibb (BMY) ended the recent trading session at $51.59, demonstrating a -0.56% swing...
Bristol-Myers Squibb Company's (NYSE:BMY) recent 4.1% pullback adds to one-year year losses,...
Simply Wall St. via Yahoo Finance· 7 months agoKey Insights Given the large stake in the stock by institutions, Bristol-Myers Squibb's stock price...
Institutional investors control 78% of Bristol-Myers Squibb Company (NYSE:BMY) and were rewarded...
Simply Wall St. via Yahoo Finance· 2 years agoTo get a sense of who is truly in control of Bristol-Myers Squibb Company (NYSE:BMY), it is...
Bristol Myers Squibb (BMY) Rises Yet Lags Behind Market: Some Facts Worth Knowing
Zacks via Yahoo Finance· 6 months agoBristol Myers Squibb (BMY) closed the latest trading day at $51.22, indicating a +0.02% change from...
Is Bristol-Myers Squibb Company (NYSE:BMY) A High Quality Stock To Own?
Simply Wall St. via Yahoo Finance· 6 months agoOne of the best investments we can make is in our own knowledge and skill set. With that in mind,...
In the wake of Bristol-Myers Squibb Company's (NYSE:BMY) latest US$8.0b market cap drop,...
Simply Wall St. via Yahoo Finance· 1 year agoKey Insights Given the large stake in the stock by institutions, Bristol-Myers Squibb's stock price...
Is Bristol Myers Squibb a Top Dividend Stock?
Motley Fool· 1 year agoBristol Myers Squibb (BMS) (NYSE: BMY), a multinational pharmaceutical company, has all the hallmarks of a top-shelf dividend stock. The company has...
Is Eli Lilly or Bristol Myers Squibb the Better Value Stock to Buy Right Now?
Motley Fool· 1 year agoWhile growth stocks boomed in the era of easy money, value stocks have returned to form as the...
The Generics Are Here: How Bristol Myers Squibb Expects Patent Losses To Hit In 2022
Investor's Business Daily· 2 years agoBristol Myers Squibb reaffirmed expectations for a $10 billion pitfall from its generics-facing...